Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas.
about
The homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesisDiagnosis and management of high risk group for gastric cancerCDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancerCdx1 and c-Myc foster the initiation of transdifferentiation of the normal esophageal squamous epithelium toward Barrett's esophagusHpSlyD inducing CDX2 and VIL1 expression mediated through TCTP protein may contribute to intestinal metaplasia in the stomachLynch syndrome-associated breast cancers do not overexpress chromosome 11-encoded mucinsPulmonary intestinal-type adenocarcinoma does not show enteric differentiation by immunohistochemical study.Reg IV is a direct target of intestinal transcriptional factor CDX2 in gastric cancerEsophageal Helicobacter pylori colonization aggravates esophageal injury caused by reflux.Animal models of stomach carcinogenesis.Gastric and intestinal claudin expression at the invasive front of gastric carcinoma.CDX1 and CDX2 expression in intestinal metaplasia, dysplasia and gastric cancerCo-expression of CDX2 and MUC2 in gastric carcinomas: correlations with clinico-pathological parameters and prognosis.Comparative analysis of gastrointestinal microbiota between normal and caudal-related homeobox 2 (cdx2) transgenic mice.CDX2 protein expression compared to alcian blue staining in the evaluation of esophageal intestinal metaplasia.Vitamin D receptor Cdx-2 polymorphism and premenopausal breast cancer risk in southern Pakistani patientsMetastasis in the gingiva from colon adenocarcinomaMUC1 and MUC2 in pancreatic neoplasiaThe homeodomain protein CDX2 is an early marker of Barrett's oesophagus.Intestinal metaplasia -the effect of Acid on the gastric mucosa and gastric carcinogenesis-CDX2 as a marker for intestinal differentiation: Its utility and limitations.Intestinal Stem Cell Markers in the Intestinal Metaplasia of Stomach and Barrett's Esophagus.Expression and significance of homeodomain protein Cdx2 in gastric carcinoma and precancerous lesions.Role of Helicobacter pylori in gastric carcinogenesis: the origin of gastric cancers and heterotopic proliferative glands in Mongolian gerbils.Methylation-dependent activation of CDX1 through NF-κB: a link from inflammation to intestinal metaplasia in the human stomach.CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signaling.Prognostic significance of Cdx2 immunohistochemical expression in gastric cancer: a meta-analysis of published literatures.Differential gene-expression profiles associated with gastric adenomaExpression of Activated Ras in Gastric Chief Cells of Mice Leads to the Full Spectrum of Metaplastic Lineage Transitions.CDX2 regulation by the RNA-binding protein MEX3A: impact on intestinal differentiation and stemness.Transcriptional regulation of the Drosophila caudal homeobox gene by DRE/DREF.Immunohistochemical biomarkers of value in distinguishing primary ovarian carcinoma from gastric carcinoma: a systematic review with statistical meta-analysis.Reversal of multidrug resistance in gastric cancer cells by CDX2 downregulationGenetic Mechanisms and Aberrant Gene Expression during the Development of Gastric Intestinal Metaplasia and Adenocarcinoma.Utilization of CDX2 expression in diagnosing pancreatic ductal adenocarcinoma and predicting prognosis.Cdx genes, inflammation, and the pathogenesis of intestinal metaplasia.Helicobacter pylori infection and gastric carcinogenesis in rodent models.A review of in vitro and in vivo models of oesophageal and gastric cancer.1,25-dihydroxyvitamin D in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma.Molecular insight in gastric cancer induction: an overview of cancer stemness genes.
P2860
Q24683173-8045B4DA-9E8B-40CF-B41C-599B190D719DQ28084323-F2F05A13-89EE-408B-9335-D6686B1E2357Q28251382-7CB1E866-4106-4C81-AE95-E9E226196E8BQ33379614-AED7C800-C381-4552-87D3-47D35AA321C9Q33720199-E7223F5F-3281-4001-A984-10B007417730Q34375540-D6A0A36D-9D2A-47AD-B13E-B22E94D00510Q34377419-40B07413-1500-47AF-9673-010023B82C56Q34469547-8F751CAA-BBC5-47EA-B002-447A740DBDFDQ34499101-8B884958-A590-4338-B588-D147CC51A0E7Q34581372-0DB3C5B9-1CD9-47CD-AC8E-10C0F04218BCQ34622776-C28DD9F0-C494-4929-B955-E8647BF84FC5Q34853497-6AAC11E7-646F-4894-94D4-91A6063880B8Q35045566-E2869D60-F45B-468F-B3BD-1AEE751C6471Q35046187-0028DA40-0B0F-4508-BD4D-72E236264AB3Q35152381-A8882BF7-4A76-49F7-88C5-CD757919C7B9Q35208354-F4CCC32E-A043-4239-AF8D-8332E86669E3Q35231883-E8A833AF-6285-4BF5-A9EB-527D35A84175Q35587636-FCD9CC8F-87C2-417B-89A3-0C7F61FBE121Q35588064-94E3C0C2-B9E6-4F37-9EFC-27D102D374A7Q35603919-9C2DD34C-4488-4726-9C09-A7323B3A9DDDQ35618815-A26B7A43-CF70-4048-9E55-5B8BA448CCD3Q35634441-08C5DAE9-42F8-439F-A8CD-C3810B8AAC85Q36082215-2D231AA7-3EA5-4B44-9E6F-C17965E71FCDQ36089366-E17DD18A-4CF9-430F-AF7B-A2E0B787537AQ36131557-658FBD3F-7925-4B76-A77B-EBCD1F6881E9Q36497247-5FACB31E-4486-4818-9DE4-D62AB4BEC7DFQ36498827-AE77D802-B04B-43BD-BE22-95D20AB7D32FQ36673781-275FDF83-B558-4662-A19B-2336BDF65E71Q36730863-9C61246E-7D9C-4755-A4A5-A144382BBD48Q36769451-C586E0C8-FDAF-4BB9-9B92-D27F9A0E3DFCQ36827503-9325D613-380F-4EE5-BB94-4CC31B9C2031Q36933835-B4816B4D-51A3-4804-95DC-D3DA1F5D6FB2Q37009280-C106D49F-C2C3-43F3-9880-14E6B5F5F056Q37468529-E39A9BEA-CC72-4CA3-949A-003313E0278CQ37529458-70E64ACF-D140-45BF-8E93-BAC5D6AD2F24Q37809363-D7E1C1E7-F54A-4768-945F-86E6583CF7CCQ38056644-6D4C2AE3-8048-40C0-A97C-E7B5778C5EAEQ38088347-2D2164C7-36B0-4F1A-BC86-DAA7529DE72EQ38111420-449EE90F-80A5-464F-B425-9A6B5F4CF1A2Q38146997-ABA10E32-17AA-4E6F-A9F8-0CEC8630A6F8
P2860
Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Expression of intestine-specif ...... plasia and gastric carcinomas.
@en
Expression of intestine-specif ...... plasia and gastric carcinomas.
@nl
type
label
Expression of intestine-specif ...... plasia and gastric carcinomas.
@en
Expression of intestine-specif ...... plasia and gastric carcinomas.
@nl
prefLabel
Expression of intestine-specif ...... plasia and gastric carcinomas.
@en
Expression of intestine-specif ...... plasia and gastric carcinomas.
@nl
P2093
P2860
P50
P356
P1476
Expression of intestine-specif ...... aplasia and gastric carcinomas
@en
P2093
Carmen De Bolós
Debra G Silberg
Jiangfu Wang
P2860
P356
10.1002/PATH.1246
P577
2003-01-01T00:00:00Z